ClinicalTrials.govpublic full text
MK-3475/BCG in High Risk Superficial Bladder Cancer
bladder cancer, urinary bladder neoplasms, mycobacterium bovis, programmed cell death 1 receptor, pembrolizumab, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 897565
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.